World Library  
Flag as Inappropriate
Email this Article

Stem cell research policy

Article Id: WHEBN0007153071
Reproduction Date:

Title: Stem cell research policy  
Author: World Heritage Encyclopedia
Language: English
Subject: Science policy, Cell therapy, Food policy, Policy Monitoring, Stem cell research
Collection: Science Policy, Stem Cell Research
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Stem cell research policy

Stem cell research policy varies significantly throughout the world. There are overlapping jurisdictions of international organizations, nations, and states or provinces. Some government policies determine what is allowed versus prohibited, whereas others outline what research can be publicly financed. Of course, all practices not prohibited are implicitly permitted. Some organizations have issued recommended guidelines for how stem cell research is to be conducted.

Contents

  • International bodies 1
    • The Hinxton Group 1.1
    • ICMS 1.2
    • ISSCR 1.3
  • Nations 2
  • References 3
  • External links 4

International bodies

The United Nations adopted a declaration on human cloning that can be interpreted as calling on member states to prohibit somatic cell nuclear transfer, or therapeutic cloning. In 2005, in a divided vote, "Member States were called on to adopt all measures necessary to prohibit all forms of human cloning in as much as they are incompatible with human dignity and the protection of human life."

The World Health Organization has opposed a ban on cloning techniques in stem cell research.

The Greece, Hungary, Iceland, Lithuania, Moldova, Portugal, Romania, San Marino, Slovakia, Slovenia, Spain, and Turkey.[2]

The Hinxton Group

Researchers, ethicists and assorted spokespersons from 14 different countries have published a set of legal and ethical guidelines relating to stem cell research, in an effort to address conflicting international laws in this area [1] [2]. The ‘Hinxton Group’ met recently for the first time, in Cambridge, and published a consensus statement calling for a ‘flexible’ regulatory framework, which can simultaneously accommodate rapid scientific advance and at the same time accommodate the diversity of international approaches towards stem cell science (ibid.). It also recommends that, in countries which oppose embryonic stem cell research, scientists should be free to pursue their research elsewhere (ibid.).

In light of the controversy surrounding Hwang Woo-Suk, the Hinxton Group has additionally recommended a number of measures intended to prevent fraud in stem cell research. The group has requested that all authors of embryonic stem cell papers submit a statement of authenticity of any new cell-lines and that the source of stem cells be clearly specified (ibid.).

On the ethical issues surrounding embryonic stem cell research, the group has additionally recommended that an international database be created, containing guidelines for ethical practice, research protocols, consent forms, and the information provided to donors (ibid.).

However, the potential for an international consensus on these matters seems remote given the complexity and diversity of regulatory frameworks in this controversial area of science, both within nations and between nations.

ICMS

The International Cellular Medicine Society is developing professional guidelines for the conduct of stem cell therapy and research.

ISSCR

The International Society for Stem Cell Research is developing guidelines for the conduct of stem cell research.

Nations

Embryonic stem cell research has divided the international community. In the European Union, stem cell research using the human embryo is permitted in Sweden, Finland, Belgium, Greece, Britain, Denmark and the Netherlands; however it is illegal in Germany, Austria, Ireland, Italy, and Portugal. The issue has similarly divided the United States, with several states enforcing a complete ban and others giving financial support.[3] Elsewhere, Japan, India, Iran, Israel, South Korea, and China are supportive, Australia is partially supportive (exempting reproductive cloning yet allowing research on embryonic stem cells that are derived from the process of IVF); however New Zealand, most of Africa (excepting South Africa) and most of South America (excepting Brazil) are restrictive.

References

  1. ^ Chapter V, Article 18 of the Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine http://conventions.coe.int/Treaty/EN/Treaties/Html/164.htm
  2. ^ Adorno, Roberto (July 2005). "The Oviedo Convention: A European Legal Framework at the Intersection of Human Rights and Health Law" (PDF). Journal of International Biotechnology Law 2 (4): 134.  
  3. ^ Mlsna, Lucas J. (2010). "Stem Cell Based Treatments and Novel Considerations for Conscience Clause Legislation".   ISSN:1549-3199. LCCN:2004212209. OCLC:OCLC 54703225.

External links

  • European Molecular Biology Organization publication
  • United Nations Declaration on Human Cloning
  • Council of Europe's Convention on Human Rights and Biomedicine
  • World Stem Cell Policy Map
  • World map of stem cell research centers
  • World Stem Cell Report
  • Stem Cell Research Reveals Clues to Disease's Origins
  • International Society for Stem Cell Research
  • Stem Cell Information from the United States National Academies
  • Federal Policy Verbatim on the Use of Stem Cells in the U.S.
  • The Hinxton Group: An International Consortium on Stem Cells, Ethics & Law
  • World Stem Cell Policies
  • Johns Hopkins Stem Cell Policy
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.